Aerogen Pharma, headquartered in Galway, Ireland, with drug development and business operations in San Mateo, California, is a clinical-stage specialty pharmaceutical company developing proprietary, inhaled medications for improved care of patients receiving oxygen and ventilatory support in acute and critical care.

Our goal is to create medically superior, proprietary and commercially differentiated combination products by combining proven therapeutic molecules with a unique, high-performance aerosol delivery system.  For our initial product programs, we have selected tried and trusted drugs and repurposed them for inhalation, with the aim of improving their safety and efficacy via targeting to the lung. Our approach is optimized for quick, efficient, consistent and user-friendly delivery of liquid medications to patients on a broad range of oxygen and ventilator support equipment.